National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period

IF 0.4 Q4 ONCOLOGY International Journal of Cancer Management Pub Date : 2023-06-21 DOI:10.5812/ijcm-127005
M. Nowroozi, E. Amini, Ehsan Mosa Farkhani, Ali Nowroozi, M. Ayati, Seyed Ali Momeni, Sepideh Mirzaei, K. Hushmandi, L. Sharifi, S. Bokaie
{"title":"National and Subnational Incidence Trend of Bladder Cancer in Iran: Report of a 12-Year Period","authors":"M. Nowroozi, E. Amini, Ehsan Mosa Farkhani, Ali Nowroozi, M. Ayati, Seyed Ali Momeni, Sepideh Mirzaei, K. Hushmandi, L. Sharifi, S. Bokaie","doi":"10.5812/ijcm-127005","DOIUrl":null,"url":null,"abstract":"Background: Bladder cancer is one of the most common cancers worldwide and also in Iran. Understanding of bladder cancer epidemiology is of great value for policymakers and assists in the prevention and early detection of the disease. Objectives: The aim of the present study was to report national and subnational incidence trends of bladder cancer in Iran between 2003 and 2015. Methods: This study investigated the age-standardized incidence rates (ASIRs) per annum of bladder cancer from 2003 to 2015 in Iran using the data from the cancer registration system of the Ministry of Health and Medical Education of Iran. The crude incidence rates were calculated by dividing incident cases by the country and province population, which were provided by the Statistic Center of Iran. Age standardization was performed using the WHO standard population, and ASIRs were compared by age, sex, and province. Results: The ASIR of bladder cancer increased from 8.35 in 2003 to 13.57 in 2015 in men. The ASIR of bladder cancer also showed a mild increase in females, 2.12 in 2003 versus 2.86 in 2015. The province of Yazd had the highest rate of bladder cancer in men, and West Azerbaijan had the highest rate for women (15.13 and 7.79 per 100,000), while Sistan va Baluchestan and Ilam had the lowest ASIRs for men and women (3.01 and 0.96 per 100,000, respectively). Conclusions: The increasing trend of bladder cancer incidence in Iran, despite the clear decreasing global trend accompanying to ongoing aging of the population highlights the diseases as a potential health problem in the upcoming years in Iran. Therefore, it is necessary for health organizations to implement effective research and control programs in the country to prevent further increases in disease burden.","PeriodicalId":44764,"journal":{"name":"International Journal of Cancer Management","volume":"27 1","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/ijcm-127005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Bladder cancer is one of the most common cancers worldwide and also in Iran. Understanding of bladder cancer epidemiology is of great value for policymakers and assists in the prevention and early detection of the disease. Objectives: The aim of the present study was to report national and subnational incidence trends of bladder cancer in Iran between 2003 and 2015. Methods: This study investigated the age-standardized incidence rates (ASIRs) per annum of bladder cancer from 2003 to 2015 in Iran using the data from the cancer registration system of the Ministry of Health and Medical Education of Iran. The crude incidence rates were calculated by dividing incident cases by the country and province population, which were provided by the Statistic Center of Iran. Age standardization was performed using the WHO standard population, and ASIRs were compared by age, sex, and province. Results: The ASIR of bladder cancer increased from 8.35 in 2003 to 13.57 in 2015 in men. The ASIR of bladder cancer also showed a mild increase in females, 2.12 in 2003 versus 2.86 in 2015. The province of Yazd had the highest rate of bladder cancer in men, and West Azerbaijan had the highest rate for women (15.13 and 7.79 per 100,000), while Sistan va Baluchestan and Ilam had the lowest ASIRs for men and women (3.01 and 0.96 per 100,000, respectively). Conclusions: The increasing trend of bladder cancer incidence in Iran, despite the clear decreasing global trend accompanying to ongoing aging of the population highlights the diseases as a potential health problem in the upcoming years in Iran. Therefore, it is necessary for health organizations to implement effective research and control programs in the country to prevent further increases in disease burden.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊朗国家和地方膀胱癌发病率趋势:12年报告
背景:膀胱癌是世界上最常见的癌症之一,在伊朗也是如此。了解膀胱癌的流行病学对决策者有很大的价值,有助于预防和早期发现该疾病。目的:本研究的目的是报告2003年至2015年间伊朗膀胱癌的国家和地方发病率趋势。方法:本研究利用伊朗卫生和医学教育部癌症登记系统的数据,调查2003 - 2015年伊朗膀胱癌的年年龄标准化发病率(asir)。粗发病率由伊朗统计中心提供的病例数除以国家和省人口计算得出。使用WHO标准人群进行年龄标准化,并按年龄、性别和省份比较asir。结果:男性膀胱癌的ASIR由2003年的8.35上升至2015年的13.57。膀胱癌的ASIR在女性中也略有上升,2003年为2.12,2015年为2.86。亚兹德省的男性膀胱癌发病率最高,西阿塞拜疆的女性膀胱癌发病率最高(15.13 / 10万和7.79 / 10万),而俾路支斯坦省和伊拉姆省的男性和女性膀胱癌发病率最低(分别为3.01 / 10万和0.96 / 10万)。结论:尽管随着人口的持续老龄化,全球趋势明显下降,但伊朗膀胱癌发病率呈上升趋势,这突显了该疾病在未来几年将成为伊朗潜在的健康问题。因此,卫生组织有必要在国内实施有效的研究和控制计划,以防止疾病负担的进一步增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
67
期刊介绍: International Journal of Cancer Management (IJCM) publishes peer-reviewed original studies and reviews on cancer etiology, epidemiology and risk factors, novel approach to cancer management including prevention, diagnosis, surgery, radiotherapy, medical oncology, and issues regarding cancer survivorship and palliative care. The scope spans the spectrum of cancer research from the laboratory to the clinic, with special emphasis on translational cancer research that bridge the laboratory and clinic. We also consider original case reports that expand clinical cancer knowledge and convey important best practice messages.
期刊最新文献
Sodium Butyrate as Histone Deacetylase Inhibitor Can Alter miR-101, ZEB1, ZEB2, and E-cadherin Expression in MDA-MB-468 Cells as Triple Negative Breast Cancer Cells Unmet Needs of Palliative Care Among Iranian Children with Cancer and Their Families: A Qualitative Study Trend of the Incidence Rate of Kidney and Ureter Cancer in Iran from 2004 to 2016 Trends in Incidence of Prostate Cancer in Iran and Its 31 Provinces During 2003 - 2016 Estimating Out-of-Pocket Payments Among Iranian Women with Breast Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1